GI
HRMY icon

GAMMA Investing’s Harmony Biosciences HRMY Stock Holding History

GAMMA Investing’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.2K Buy
693
+66
+11% +$2.55K ﹤0.01% 2759
2026
Q2 		$22.8K Buy
627
+126
+25% +$3.98K ﹤0.01% 2772
2026
Q1 		$14K Sell
501
-691
-58% -$22.7K ﹤0.01% 2892
2025
Q4 		$44.6K Sell
1,192
-254
-18% -$8.35K ﹤0.01% 2138
2025
Q3 		$39.9K Sell
1,446
-259
-15% -$8.92K ﹤0.01% 2143
2025
Q2 		$53.9K Sell
1,705
-1,224
-42% -$39.4K ﹤0.01% 1893
2025
Q1 		$97.2K Buy
2,929
+2,022
+223% +$72.5K 0.01% 1281
2024
Q4 		$31.2K Buy
907
+436
+93% +$15K ﹤0.01% 2018
2024
Q3 		$18.8K Buy
471
+189
+67% +$6.64K ﹤0.01% 2141
2024
Q2 		$8.51K Buy
282
+143
+103% +$4.3K ﹤0.01% 2331
2024
Q1 		$4.67K Buy
139
+44
+46% +$1.41K ﹤0.01% 2437
2023
Q4 		$3K Buy
+95
New +$2.65K ﹤0.01% 2441

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

GAMMA Investing's HRMY Position: Q3 2026 in Review

GAMMA Investing increased its Harmony Biosciences (HRMY) stake by 11% in Q3 2026, buying an estimated $2.55K and bringing the position to 693 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2759.

GAMMA Investing first reported a position in HRMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $97.2K in Q1 2025. 9 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • GAMMA Investing held 693 shares of Harmony Biosciences worth $27.2K as of Q3 2026.
  • GAMMA Investing bought 66 Harmony Biosciences shares in Q3 2026, an estimated $2.55K.
  • Harmony Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2759 holding.
  • GAMMA Investing first reported a position in Harmony Biosciences in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Harmony Biosciences position peaked at $97.2K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.